Evalar, one of the largest pharmaceutical companies in Russia for the production of natural medicines and dietary supplements, is expanding its production capacity – a new three-story production building was officially opened at the plant in Biysk. It includes two sites for the production of non-sterile finished dosage forms, a warehouse of finished products, administrative and household, laboratory and engineering units.
The construction work at the site for the production of solid dosage forms for synthetic raw materials began in 2013. The total area of the site is 1400 m2. Its total estimated cost is 5 billion rubles.
The ceremonial opening of the production complex took place on July 12, 2019. The Plenipotentiary of the Russian President in the Siberian Federal District Sergey Menyaylo, the Governor of the Altai Territory Viktor Tomenko, the First Deputy Minister of Industry and Trade of the Russian Federation Sergey Tsyb, as well as representatives of the administration of the Altai Territory and the city of Biysk, where the production is located, attended the ceremony.
According to Larisa Prokopieva, General Director of the Evalar Holding,
„The development of the drug portfolio is a key priority for the development of the company today. Now the company’s portfolio includes 27 drugs. At the same time, the company, relying on its many years of experience working with medicinal plants, plans to largely focus on the development and production of herbal medicines. The opening of the new facility will provide millions of consumers with access to high-quality herbal preparations.”
The opening of the production complex will allow Evalar to produce competitive analogs of expensive imported drugs that are 40-50% cheaper than the prices of analogs. First Deputy Minister of Industry and Trade Sergey Tsyb highly appreciated the company’s contribution to the implementation of the state program for the development of the pharmaceutical industry.
Evalar was founded in 1991. The Company’s line of business includes the manufacturing, fabricating, or processing of drugs in pharmaceutical preparations for human or veterinary use.